Alphyn Biologics Maryland Alberta

Alphyn Biologics Reports Positive Results from First Cohort of Phase 2a Trial of Mild-to-Moderate Atopic Dermatitis Treatment

View original content:https://www.prnewswire.co.uk/news-releases/alphyn-biologics-reports-positive-results-from-first-cohort-of-phase-2a-trial-of-mild-to-moderate-atopic-dermatitis-treatment-301713110.html